UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever

Vaccine, 2011-09, Vol.29 (42), p.7251-7260

2011

Volltextzugriff (PDF)

West Nile Virus Vaccination Protects against Usutu Virus Disease in Mice

Viruses, 2021-11, Vol.13 (12), p.2352

2021

Volltextzugriff (PDF)

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus

Nature communications, 2021-12, Vol.12 (1), p.7320-7320, Article 7320

2021

Volltextzugriff (PDF)

N-linked glycosylation of the West Nile virus envelope protein is not a requisite for avian virulence or vector competence

PLoS neglected tropical diseases, 2019-07, Vol.13 (7), p.e0007473-e0007473

2019

Volltextzugriff (PDF)

Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques

The American journal of tropical medicine and hygiene, 2011-06, Vol.84 (6), p.978-987

2011

Volltextzugriff (PDF)

Mutational analysis of the West Nile virus NS4B protein

Virology (New York, N.Y.), 2012-04, Vol.426 (1), p.22-33

2012

Volltextzugriff (PDF)

Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice

Vaccine, 2012-02, Vol.30 (8), p.1513-1520

2012

Volltextzugriff (PDF)

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax)

PLoS neglected tropical diseases, 2013-05, Vol.7 (5), p.e2243

2013

Volltextzugriff (PDF)

Envelope Protein Glycosylation Status Influences Mouse Neuroinvasion Phenotype of Genetic Lineage 1 West Nile Virus Strains

Journal of Virology, 2005-07, Vol.79 (13), p.8339-8347

2005

Volltextzugriff (PDF)

Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection

Virology (New York, N.Y.), 2014-05, Vol.456, p.238-246

2014

Volltextzugriff (PDF)

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness

Vaccine, 2011-12, Vol.29 (52), p.9702-9710

2011

Volltextzugriff (PDF)

West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms

PLoS neglected tropical diseases, 2016-08, Vol.10 (8), p.e0004938-e0004938

2016

Volltextzugriff (PDF)

Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III

Virology (New York, N.Y.), 2016-09, Vol.496, p.97-105

2016

Volltextzugriff (PDF)

Combating West Nile Virus Disease — Time to Revisit Vaccination

The New England journal of medicine, 2023-05, Vol.388 (18), p.1633-1636

2023

Volltextzugriff (PDF)

The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion

Virology (New York, N.Y.), 2010-01, Vol.396 (2), p.305-315

2010

Volltextzugriff (PDF)

Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus

Journal of antimicrobial chemotherapy, 2008-09, Vol.62 (3), p.555-565

2008

Volltextzugriff (PDF)

Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion

Virology (New York, N.Y.), 2011-04, Vol.413 (1), p.118-127

2011

Volltextzugriff (PDF)

Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes

Virology (New York, N.Y.), 2010-10, Vol.406 (2), p.328-335

2010

Volltextzugriff (PDF)

Formulation and production of a blood‐free and chemically defined virus production media for VERO cells

Biotechnology and bioengineering, 2020-11, Vol.117 (11), p.3277-3285

2020

Volltextzugriff (PDF)

Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines

Vaccine, 2011-10, Vol.29 (43), p.7456-7462

2011

Volltextzugriff (PDF)

Mutations in the West Nile prM protein affect VLP and virion secretion in vitro

Virology (New York, N.Y.), 2012-11, Vol.433 (1), p.35-44

2012

Volltextzugriff (PDF)

Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults

The American journal of tropical medicine and hygiene, 2006-06, Vol.74 (6), p.1078-1083

2006

Volltextzugriff (PDF)

The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure

Journal of clinical microbiology, 2021-07, Vol.59 (8), p.e0040021

2021

Volltextzugriff (PDF)

Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers

Journal of Virology, 2005-04, Vol.79 (8), p.5116-5128

2005

Volltextzugriff (PDF)

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

The Journal of infectious diseases, 2015-10, Vol.212 (7), p.1032-1041

2015

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever

West Nile Virus Vaccination Protects against Usutu Virus Disease in Mice

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus

N-linked glycosylation of the West Nile virus envelope protein is not a requisite for avian virulence or vector competence

Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques

Mutational analysis of the West Nile virus NS4B protein

Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax)

Envelope Protein Glycosylation Status Influences Mouse Neuroinvasion Phenotype of Genetic Lineage 1 West Nile Virus Strains

Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection

Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness

West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms

Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III

Combating West Nile Virus Disease — Time to Revisit Vaccination

The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion

Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus

Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion

Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes

Formulation and production of a blood‐free and chemically defined virus production media for VERO cells

Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines

Mutations in the West Nile prM protein affect VLP and virion secretion in vitro

Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults

The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure

Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

Suchergebnisse filtern